A citation-based method for searching scientific literature

Arpita Basu, Alicia J Jenkins, Julie A Stoner, Ying Zhang, Richard L Klein, Maria F Lopes-Virella, W Timothy Garvey, David S Schade, Jamie Wood, Petar Alaupovic, Timothy J Lyons. J Lipid Res 2018
Times Cited: 3







List of co-cited articles
11 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


High-Density Lipoprotein Subspecies Defined by Apolipoprotein C-III and Subclinical Atherosclerosis Measures: MESA (The Multi-Ethnic Study of Atherosclerosis).
Sarah A Aroner, Manja Koch, Kenneth J Mukamal, Jeremy D Furtado, James H Stein, Matthew C Tattersall, Robyn L McClelland, Majken K Jensen. J Am Heart Assoc 2018
10
66

Triglycerides, apo C3 and Lp B:C3 and cardiovascular risk in type II diabetes.
N Gervaise, M A Garrigue, G Lasfargues, P Lecomte. Diabetologia 2000
74
66


Burden of cardiovascular risk factors and disease among patients with type 1 diabetes: results of the Australian National Diabetes Audit (ANDA).
Anthony Pease, Arul Earnest, Sanjeeva Ranasinha, Natalie Nanayakkara, Danny Liew, Natalie Wischer, Sofianos Andrikopoulos, Sophia Zoungas. Cardiovasc Diabetol 2018
12
66



Oxidized LDL and AGE-LDL in circulating immune complexes strongly predict progression of carotid artery IMT in type 1 diabetes.
Kelly J Hunt, Nathaniel Baker, Patricia Cleary, Jye-Yu Backlund, Timothy Lyons, Alicia Jenkins, Gabriel Virella, Maria F Lopes-Virella. Atherosclerosis 2013
22
66


Analysis of plasma lipids and apolipoproteins in insulin-dependent and noninsulin-dependent diabetics.
E R Briones, S J Mao, P J Palumbo, W M O'Fallon, W Chenoweth, B A Kottke. Metabolism 1984
114
66

Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes.
Jenny E Kanter, Baohai Shao, Farah Kramer, Shelley Barnhart, Masami Shimizu-Albergine, Tomas Vaisar, Mark J Graham, Rosanne M Crooke, Clarence R Manuel, Rebecca A Haeusler,[...]. J Clin Invest 2019
37
66

Apolipoprotein C-III protein concentrations and gene polymorphisms in Type 1 diabetes: associations with microvascular disease complications in the DCCT/EDIC cohort.
Richard L Klein, M Brent McHenry, Kerry H Lok, Steven J Hunter, Ngoc-Anh Le, Alicia J Jenkins, Deyi Zheng, Andrea Semler, Grier Page, W Virgil Brown,[...]. J Diabetes Complications 2005
29
66




Serum apolipoproteins are associated with systemic and retinal microvascular function in people with diabetes.
Muhammad Bayu Sasongko, Tien Y Wong, Thanh T Nguyen, Ryo Kawasaki, Alicia J Jenkins, Jonathan Shaw, Carol Robinson, Jie Jin Wang. Diabetes 2012
21
33

Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment.
John J P Kastelein, Wim A van der Steeg, Ingar Holme, Michael Gaffney, Nilo B Cater, Philip Barter, Prakash Deedwania, Anders G Olsson, S Matthijs Boekholdt, David A Demicco,[...]. Circulation 2008
326
33


Association of apolipoprotein B with incident type 2 diabetes in an aboriginal Canadian population.
Sylvia H Ley, Stewart B Harris, Philip W Connelly, Mary Mamakeesick, Joel Gittelsohn, Thomas M Wolever, Robert A Hegele, Bernard Zinman, Anthony J Hanley. Clin Chem 2010
38
33

Serum apolipoprotein profile of patients with chronic renal failure.
P O Attman, P Alaupovic, A Gustafson. Kidney Int 1987
121
33

Postprandial effect of n-3 polyunsaturated fatty acids on apolipoprotein B-containing lipoproteins and vascular reactivity in type 2 diabetes.
Kirsten F Hilpert, Sheila G West, Penny M Kris-Etherton, Kari D Hecker, Nancy M Simpson, Petar Alaupovic. Am J Clin Nutr 2007
32
33


Nuclear magnetic resonance-determined lipoprotein subclass profile in the DCCT/EDIC cohort: associations with carotid intima-media thickness.
T J Lyons, A J Jenkins, D Zheng, R L Klein, J D Otvos, Y Yu, D T Lackland, D McGee, M B McHenry, M Lopes-Virella,[...]. Diabet Med 2006
47
33



Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions.
Meenakshi Sundaram, Shumei Zhong, Maroun Bou Khalil, Philip H Links, Yang Zhao, Jahangir Iqbal, M Mahmood Hussain, Robin J Parks, Yuwei Wang, Zemin Yao. J Lipid Res 2010
109
33

Nuclear magnetic resonance-determined lipoprotein subclasses and carotid intima-media thickness in type 1 diabetes.
Arpita Basu, Alicia J Jenkins, Ying Zhang, Julie A Stoner, Richard L Klein, Maria F Lopes-Virella, W Timothy Garvey, Timothy J Lyons. Atherosclerosis 2016
13
33

Apolipoprotein C-III: understanding an emerging cardiovascular risk factor.
Esther M M Ooi, P Hugh R Barrett, Dick C Chan, Gerald F Watts. Clin Sci (Lond) 2008
178
33

Circulating Apolipoprotein E Concentration and Cardiovascular Disease Risk: Meta-analysis of Results from Three Studies.
Reecha Sofat, Jackie A Cooper, Meena Kumari, Juan P Casas, Jacqueline P Mitchell, Jayshree Acharya, Simon Thom, Alun D Hughes, Steve E Humphries, Aroon D Hingorani. PLoS Med 2016
24
33

Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC.
John M Lachin, Neil H White, Dean P Hainsworth, Wanjie Sun, Patricia A Cleary, David M Nathan. Diabetes 2015
154
33

Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes.
S P Laing, A J Swerdlow, S D Slater, A C Burden, A Morris, N R Waugh, W Gatling, P J Bingley, C C Patterson. Diabetologia 2003
475
33

Effects of lovastatin on ApoA- and ApoB-containing lipoproteins. Families in a subpopulation of patients participating in the Monitored Atherosclerosis Regression Study (MARS).
P Alaupovic, H N Hodis, C Knight-Gibson, W J Mack, L LaBree, L Cashin-Hemphill, C N Corder, D M Kramsch, D H Blankenhorn. Arterioscler Thromb 1994
48
33

ApoC-III bound to apoB-containing lipoproteins increase with insulin resistance in Cherokee Indian youth.
Piers R Blackett, Kathleen S Blevins, Elaine Quintana, Martha Stoddart, Wenyu Wang, Petar Alaupovic, Elisa T Lee. Metabolism 2005
15
33




Oxidized LDL immune complexes and coronary artery calcification in type 1 diabetes.
Maria F Lopes-Virella, Nathaniel L Baker, Kelly J Hunt, John Lachin, David Nathan, G Virella. Atherosclerosis 2011
33
33


Identification of apoB-containing lipoprotein families in NIDDM.
P Alaupovic, J M Bard, M Tavella, D Shafer. Diabetes 1992
21
33

Progression of carotid artery intima-media thickness during 12 years in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study.
Joseph F Polak, Jye-Yu C Backlund, Patricia A Cleary, Anita P Harrington, Daniel H O'Leary, John M Lachin, David M Nathan. Diabetes 2011
97
33

High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes.
Maria F Lopes-Virella, Nathaniel L Baker, Kelly J Hunt, Timothy J Lyons, Alicia J Jenkins, Gabriel Virella. Diabetes Care 2012
43
33


The relationship of blood glucose with cardiovascular disease is mediated over time by traditional risk factors in type 1 diabetes: the DCCT/EDIC study.
Ionut Bebu, Barbara H Braffett, Rodica Pop-Busui, Trevor J Orchard, David M Nathan, John M Lachin. Diabetologia 2017
42
33

Both serum apolipoprotein B and the apolipoprotein B/apolipoprotein A-I ratio are associated with carotid intima-media thickness.
Fei Huang, Zhi Yang, Baihui Xu, Yufang Bi, Min Xu, Yu Xu, Jieli Lu, Yu Liu, Meng Dai, Wenzhong Zhou,[...]. PLoS One 2013
22
33

The risk of cardiovascular events with increased apolipoprotein CIII: A systematic review and meta-analysis.
Moritz C Wyler von Ballmoos, Bernhard Haring, Frank M Sacks. J Clin Lipidol 2015
81
33

Apolipoprotein B-containing lipoprotein subclasses as risk factors for cardiovascular disease in patients with rheumatoid arthritis.
N Knowlton, J A Wages, M B Centola, J Giles, J Bathon, C Quiroga, P Alaupovic. Arthritis Care Res (Hoboken) 2012
13
33

Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein.
R C Kowal, J Herz, K H Weisgraber, R W Mahley, M S Brown, J L Goldstein. J Biol Chem 1990
377
33

Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus.
David M Nathan, John Lachin, Patricia Cleary, Trevor Orchard, David J Brillon, Jye-Yu Backlund, Daniel H O'Leary, Saul Genuth. N Engl J Med 2003
599
33

High-Density Lipoprotein Subspecies Defined by Presence of Apolipoprotein C-III and Incident Coronary Heart Disease in Four Cohorts.
Majken K Jensen, Sarah A Aroner, Kenneth J Mukamal, Jeremy D Furtado, Wendy S Post, Michael Y Tsai, Anne Tjønneland, Joseph F Polak, Eric B Rimm, Kim Overvad,[...]. Circulation 2018
53
33

High density lipoprotein with apolipoprotein C-III is associated with carotid intima-media thickness among generally healthy individuals.
Rain Yamamoto, Frank M Sacks, Frank B Hu, Bernard Rosner, Jeremy D Furtado, Sarah A Aroner, Ele Ferrannini, Simona Baldi, Michaela Kozakova, Beverley Balkau,[...]. Atherosclerosis 2018
6
33

High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database.
Sabita S Soedamah-Muthu, John H Fuller, Henrietta E Mulnier, Veena S Raleigh, Ross A Lawrenson, Helen M Colhoun. Diabetes Care 2006
237
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.